{"id":"CHEMBL1090090","canonicalSmiles":"NC(=O)c1ccc(N(C(N)=O)c2c(F)cccc2F)nc1-c1ccc(F)cc1F","inchiKey":"FYSRKRZDBHOFAY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VX-702","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["VX-702","Vx-702"],"crossReferences":{"PubChem":["103905258","137275870"],"drugbank":["DB05470"]},"linkedTargets":{"rows":["ENSG00000112062"],"count":1},"linkedDiseases":{"rows":["EFO_0000685"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL110739","canonicalSmiles":"C[C@]12C[C@H](O)[C@H]3[C@@H](CCC4=CC(=O)CC[C@@]43C)[C@@H]1CC[C@@H]2C(=O)CO","inchiKey":"OMFXVFTZEKFJBZ-HJTSIMOOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CORTICOSTERONE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["11-b,21-Dihydroxypregn-3,20-dione","17-Deoxycortisol","Corticosteron","Corticosterone","Kendall's compound b","NSC-9705","Preg-4-ene-3,20-dione,11-b,21-dihydroxy-","Reichstein's substance h"],"crossReferences":{"PubChem":["144204430","144208564","144213947","170466845","17389502","26751495","56423132","855741","90341091"],"Wikipedia":["Corticosterone"],"drugbank":["DB04652"],"chEBI":["16827"]},"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL1182","canonicalSmiles":"C[N+](C)(C)CC(=O)[O-]","inchiKey":"KWIUHFFTVRNATP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GLYCINEBETAINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["2-(Trimethylammonio)Acetate"],"crossReferences":{"PubChem":["144207060","144211476"],"Wikipedia":["Trimethylglycine"],"drugbank":["DB06756"],"chEBI":["17750"]},"childChemblIds":["CHEMBL3181853"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1195","canonicalSmiles":"CCCOc1cc(N)ccc1C(=O)OCCN(CC)CC","inchiKey":"CAJIGINSTLKQMM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PROPOXYCAINE","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Propoxycaine"],"crossReferences":{"PubChem":["11112410"],"Wikipedia":["Propoxycaine"],"drugbank":["DB09342"],"chEBI":["8496"]},"childChemblIds":["CHEMBL1769"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982."}
{"id":"CHEMBL1200398","canonicalSmiles":"Clc1ccc(CCC(Cn2ccnc2)Sc2c(Cl)cccc2Cl)cc1.O=[N+]([O-])O","inchiKey":"ZHPWRQIPPNZNML-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BUTOCONAZOLE NITRATE","yearOfFirstApproval":1985,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1295","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Butoconazole nitrate","Femstat","Femstat 3","Gynazole","Gynazole-1"],"synonyms":["Butoconazole nitrate","RS-35887","RS-35887-00-10-3"],"crossReferences":{"PubChem":["144204175","170464901","56463027"],"chEBI":["3241"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1985 and has 1 investigational indication."}
{"id":"CHEMBL1200469","canonicalSmiles":"CN(C)CCCN1c2ccccc2Sc2ccccc21.Cl","inchiKey":"JIVSXRLRGOICGA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PROMAZINE HYDROCHLORIDE","yearOfFirstApproval":1956,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL564","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Prazine","Promazine Granules","Promazine hydrochloride","Protactyl","Sparine","Tranquazine","Verophene"],"synonyms":["NSC-17468","Promazine chloride","Promazine hcl","Promazine hydrochloride"],"crossReferences":{"PubChem":["144203786","170464766","26747628","26747629","50106839","50106840","50106841","56422376","57288080","855749"],"chEBI":["8460"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1956."}
{"id":"CHEMBL1200632","canonicalSmiles":"CCCCCCCCCCCCCCCC(=O)O[C@@H]1[C@@H](O)[C@@H](O)[C@@H]([C@H](NC(=O)[C@@H]2C[C@@H](CCC)CN2C)[C@H](C)Cl)O[C@@H]1SC.Cl","inchiKey":"GTNDZRUWKHDICY-DJHAJVGHSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"CLINDAMYCIN PALMITATE HYDROCHLORIDE","yearOfFirstApproval":1986,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1201289","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cleocin","Clindamycin palmitate hydrochloride"],"synonyms":["Clindamycin palmitate hcl","Clindamycin palmitate hydrochloride","NSC-759141","U-25,179 E","U-25179-E","U-25179E"],"crossReferences":{"DailyMed":["clindamycin%20palmitate%20hydrochloride"],"PubChem":["144206726"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1986 and is indicated for infection and acne and has 1 investigational indication. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1200656","canonicalSmiles":"C[C@@H]1C/C=C/C=C/C=C/C=C/[C@H](O[C@@H]2O[C@H](C)[C@@H](O)[C@H](N)[C@@H]2O)C[C@@H]2O[C@](O)(C[C@@H](O)C[C@H]3O[C@@H]3/C=C/C(=O)O1)C[C@H](O)[C@H]2C(=O)O","inchiKey":"NCXMLFZGDNKEPB-FFPOYIOWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NATAMYCIN","yearOfFirstApproval":1978,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Myprozine","Natacyn","Pimafucin","Pimaricin"],"synonyms":["ANTIBIOTIC A-5283","CL 12,625","CL-12625","Delvocid","E-235","E235","INS NO.235","INS-235","Mycophyt","Myprozine","NSC-759167","Natamycin","Pimaracin","Pimaricin","Synogil","Tennecetin"],"crossReferences":{"DailyMed":["natamycin"],"PubChem":["144204112"],"Wikipedia":["Natamycin"],"drugbank":["DB00826"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1978 and is indicated for infection and eye infection and has 2 investigational indications."}
{"id":"CHEMBL1200691","canonicalSmiles":"CC(=O)[O-].CC(=O)[O-].[Mg+2]","inchiKey":"UEGPKNKPLBYCNK-UHFFFAOYSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"MAGNESIUM ACETATE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Acetic acid, magnesium salt","Magnesium acetate","Magnesium acetate anhydrous","Magnesium acetate, mg(oac)2","NSC-75798"],"crossReferences":{"DailyMed":["magnesium%20acetate"],"DrugCentral":["4489"],"PubChem":["144209755"],"Wikipedia":["Magnesium_acetate"],"drugbank":["DB13996"],"chEBI":["62964"]},"childChemblIds":["CHEMBL3989858"],"description":"Small molecule drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL1200879","canonicalSmiles":"CC(=O)CC(c1ccccc1)c1c([O-])c2ccccc2oc1=O.[Na+]","inchiKey":"KYITYFHKDODNCQ-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":true,"name":"WARFARIN SODIUM","yearOfFirstApproval":1954,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1464","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Athrombin","Coumadin","Jantoven","Marevan","Panwarfin","Warfarin sodium"],"synonyms":["Aldocumar","Apo-warfarin","Prothromadin","Sodium warfarin","Warfarin sodium","Warfarin sodium salt","Warfarinum natricum","Zoocoumarin sodium salt"],"crossReferences":{"DailyMed":["warfarin%20sodium"],"PubChem":["144211862","50085469"]},"linkedTargets":{"rows":["ENSG00000167397"],"count":1},"linkedDiseases":{"rows":["HP_0001907","EFO_0000275","EFO_0003827","EFO_0000712","EFO_0009557","EFO_0003907","EFO_0000612","HP_0004936","EFO_0004239"],"count":9},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1954 and has 7 approved indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1200887","canonicalSmiles":"COc1cc(C(=O)NCc2ccc(OCCN(C)C)cc2)cc(OC)c1OC.Cl","inchiKey":"WIIZEEPFHXAUND-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TRIMETHOBENZAMIDE HYDROCHLORIDE","yearOfFirstApproval":1974,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1201256","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Tigan","Trimethobenzamide hydrochloride","Trimethobenzamide hydrochloride preservative free"],"synonyms":["NSC-37882","Trimethobenzamide HCl","Trimethobenzamide hcl","Trimethobenzamide hydrochloride"],"crossReferences":{"DailyMed":["trimethobenzamide%20hydrochloride"],"PubChem":["144204016","170465132","26748292","56463340"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1974 and is indicated for post operative nausea and vomiting and has 1 investigational indication."}
{"id":"CHEMBL1201042","canonicalSmiles":"CC(O)(P(=O)([O-])O)P(=O)([O-])O.[Na+].[Na+]","inchiKey":"GWBBVOVXJZATQQ-UHFFFAOYSA-L","drugType":"Small molecule","blackBoxWarning":false,"name":"ETIDRONATE DISODIUM","yearOfFirstApproval":1977,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL871","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Didronel","Didronel iv","Didronel pmo","Etidronate disodium"],"synonyms":["Disodium etidronate","Etidronate disodium","Etidronic acid disodium salt","NSC-759157","Turpinal 2nz"],"crossReferences":{"PubChem":["11112988","144205149","170464730"],"chEBI":["4906"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1977."}
{"id":"CHEMBL1201746","canonicalSmiles":"C#CCC(Cc1cnc2nc(N)nc(N)c2n1)c1ccc(C(=O)N[C@@H](CCC(=O)O)C(=O)O)cc1","inchiKey":"OGSBUKJUDHAQEA-WMCAAGNKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PRALATREXATE","yearOfFirstApproval":2009,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Folotyn"],"synonyms":["NSC-754230","PDX","Pralatrexate"],"crossReferences":{"DailyMed":["pralatrexate"],"PubChem":["144206459"],"Wikipedia":["Pralatrexate"],"drugbank":["DB06813"],"chEBI":["71223"]},"linkedTargets":{"rows":["ENSG00000228716"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","EFO_0006859","MONDO_0019471","MONDO_0008170","EFO_0002913","MONDO_0002087","EFO_0000305","EFO_0003060","EFO_0000311","EFO_0000211","MONDO_0015760","MONDO_0002158","EFO_0003032","MONDO_0008903","EFO_0000574","EFO_0006544","EFO_0001378","EFO_1001051","EFO_1000785","MONDO_0000430"],"count":20},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2009 and has 5 approved and 14 investigational indications."}
{"id":"CHEMBL121790","canonicalSmiles":"Cc1cccc(-c2nn3c(c2-c2ccc(F)cc2)CCC3)n1","inchiKey":"NBDZLUOYAAVYHF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL121790","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04480"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1229971","canonicalSmiles":"O=c1[nH]cnc2c1ncn2[C@H]1C[C@H](O)[C@@H](CO)O1","inchiKey":"VGONTNSXDCQUGY-RRKCRQDMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DEOXYINOSINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["26755575"],"drugbank":["DB02380"],"chEBI":["28997"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1231","canonicalSmiles":"CCN(CC)CC#CCOC(=O)C(O)(c1ccccc1)C1CCCCC1","inchiKey":"XIQVNETUBQGFHX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OXYBUTYNIN","yearOfFirstApproval":1975,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Anturol","Contimin 2.5","Contimin 5","Cystrin","Ditropan","Ditropan xl","Kentera","Lyrinel xl","Oxybutynin","Oxytrol","Oxytrol for women","Promictuline","Urimin"],"synonyms":["Ditropan","Oxybutynin"],"crossReferences":{"DailyMed":["oxybutynin","oxybutynin%20chloride"],"PubChem":["174006905","50105262","90341037"],"Wikipedia":["Oxybutynin"],"drugbank":["DB01062"],"chEBI":["7856"]},"childChemblIds":["CHEMBL1133"],"linkedTargets":{"rows":["ENSG00000133019","ENSG00000181072"],"count":2},"linkedDiseases":{"rows":["MONDO_0024290","EFO_0006865","HP_0001268","EFO_0001663","EFO_0009562","HP_0001347","EFO_0003103","EFO_0000512","HP_0000020","HP_0000975","EFO_1000781","EFO_0003918","HP_0000011","EFO_0003877","EFO_0003956","HP_0000103"],"count":16},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1975 and has 4 approved and 10 investigational indications."}
{"id":"CHEMBL123154","canonicalSmiles":"O=C(O)c1cc(-c2ccc(Cl)cc2Cl)ccc1O","inchiKey":"SKAFZYDMDHPPJM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL123154","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07047"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1231592","canonicalSmiles":"CC(C)CCC[C@@H](C)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](OS(=O)(=O)O)CC[C@]4(C)[C@H]3CC[C@@]21C","inchiKey":"BHYOQNUELFTYRT-DPAQBDIFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1231592","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB01990"],"chEBI":["41321"]},"childChemblIds":["CHEMBL4475544"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1232181","canonicalSmiles":"O=C(O)C(c1ccccc1)c1ccccc1","inchiKey":"PYHXGXCGESYPCW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIPHENYLACETIC ACID","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["47193691"],"drugbank":["DB03588"],"chEBI":["41967"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1232182","canonicalSmiles":"OCc1cccc(F)c1F","inchiKey":"JSFGDUIJQWWBGY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"2,3-Difluorobenzyl Alcohol","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["2,3-Difluorobenzyl Alcohol"],"crossReferences":{"drugbank":["DB04312"],"chEBI":["41883"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1233249","canonicalSmiles":"CC(C)CCC[C@@](C)(O)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@@]21C","inchiKey":"MCKLJFJEQRYRQT-MGNSQDQZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1233249","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04704"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1233511","canonicalSmiles":"O=P(O)(O)O[C@H]1[C@H](OP(=O)(O)O)[C@@H](OP(=O)(O)O)[C@H](OP(=O)(O)O)[C@@H](OP(=O)(O)O)[C@H]1OP(=O)(O)O","inchiKey":"IMQLKJBTEOYOSI-GPIVLXJGSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PHYTIC ACID","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Alkalovert","Dermofeel pa-3","E391","Exfoderm","Fytic acid","Inositol hexaphosphate","Inositol hexaphosphoric acid","Inositolhexaphosphoric acid","NSC-269896","Phytic acid","Phytic acid solution"],"crossReferences":{"drugbank":["DB14981"],"chEBI":["17401"]},"childChemblIds":["CHEMBL3989600","CHEMBL2106435"],"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL1234904","canonicalSmiles":"Nc1ncc(C(=O)c2cccc(Br)c2)o1","inchiKey":"YDCMMVTWXORJGO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1234904","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08314"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1240705","canonicalSmiles":"O=C(O)C1=CC[C@@H]2CC(=O)N12","inchiKey":"BSIMZHVOQZIAOY-SCSAIBSYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CARBAPENEM","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["(5r)-carbapenem","Antibiotic tan 458","Carbapenem","Carbapenem, (5r)-","SQ-27860"],"crossReferences":{"chEBI":["615"]},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL1357648","canonicalSmiles":"CCN(CC)Cc1cc(Nc2ccnc3cc(Cl)ccc23)ccc1O.Cl.Cl.O.O","inchiKey":"YVNAYSHNIILOJS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AMODIAQUINE HYDROCHLORIDE","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL682","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Camoquin","Camoquin hydrochloride"],"synonyms":["Amodiaquine hcl","Amodiaquine hydrochloride","Amodiaquini hydrochloridum","NSC-755863"],"crossReferences":{"PubChem":["11112979","144204316","174006660"],"chEBI":["50652"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982."}
{"id":"CHEMBL136560","canonicalSmiles":"C[C@H](N)[C@H](O)c1ccccc1","inchiKey":"DLNKOYKMWOXYQA-CBAPKCEASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"(1R,2S)-PHENYLPROPANOLAMINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"Wikipedia":["Phenylpropanolamine"],"drugbank":["DB00397"],"chEBI":["80680"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1373467","canonicalSmiles":"O=c1c(-c2ccccc2)c1-c1ccccc1","inchiKey":"HCIBTBXNLVOFER-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1373467","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144205875","170465593","26719757","29217871"],"drugbank":["DB12173"],"chEBI":["53074"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL139367","canonicalSmiles":"CCC(CC)[C@H](NC(C)=O)[C@@H]1[C@H](O)[C@@H](C(=O)O)C[C@H]1NC(=N)N","inchiKey":"XRQDFNLINLXZLB-CKIKVBCHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PERAMIVIR","yearOfFirstApproval":2014,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Peramivir","RWJ-270201"],"crossReferences":{"DailyMed":["peramivir"],"drugbank":["DB06614"],"chEBI":["85202"]},"childChemblIds":["CHEMBL3989402"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2014 and is indicated for viral disease and influenza and has 1 investigational indication."}
{"id":"CHEMBL142652","canonicalSmiles":"OC[C@H]1O[C@@H](Oc2cc(O)cc(/C=C/c3ccc(O)cc3)c2)[C@H](O)[C@@H](O)[C@@H]1O","inchiKey":"HSTZMXCBWJGKHG-CUYWLFDKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PICEID","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["(E)-Piceid","(E)-Polydatin","Piceid","Polydatin","Resveratrol 3-.beta.-mono-d-glucoside","Trans-Piceid","Trans-polydatin"],"crossReferences":{"PubChem":["26719879","49681745","525087"],"Wikipedia":["Piceid"],"drugbank":["DB11263"],"chEBI":["8198"]},"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL148169","canonicalSmiles":"Cc1cc(COc2ccc([C@]3(C)CCN([C@H](C)C(=O)NO)C3=O)cc2)c2ccccc2n1","inchiKey":"YDMIPBHQKFOFQW-NSYGIPOTSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IK-682","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["IK-682"],"crossReferences":{"drugbank":["DB07145"],"chEBI":["40083"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1585","canonicalSmiles":"O=C(CCBr)N1CCN(C(=O)CCBr)CC1","inchiKey":"NJBFOOCLYDNZJN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PIPOBROMAN","yearOfFirstApproval":1966,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Vercyte"],"synonyms":["A-8103","NSC-25154","Pipobroman"],"crossReferences":{"PubChem":["144204955","170465158","26748793","86412"],"Wikipedia":["Pipobroman"],"drugbank":["DB00236"],"chEBI":["8242"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1966 and is indicated for neoplasm and has 1 investigational indication."}
{"id":"CHEMBL1637","canonicalSmiles":"Cl.Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)C2(F)F)c(=O)n1","inchiKey":"OKKDEIYWILRZIA-OSZBKLCCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GEMCITABINE HYDROCHLORIDE","yearOfFirstApproval":1996,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL888","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Gemcitabine hydrochloride","Gemzar","Infugem"],"synonyms":["Gemcitabine (as hydrochloride)","Gemcitabine hcl","Gemcitabine hydrochloride","Gemzar","LY-188011","LY-188011 HYDROCHLORIDE","LY188011 HYDROCHLORIDE"],"crossReferences":{"DailyMed":["gemcitabine%20hydrochloride"],"PubChem":["144206197","170465129"],"chEBI":["31647"]},"linkedTargets":{"rows":["ENSG00000177084","ENSG00000101868","ENSG00000062822","ENSG00000146143","ENSG00000148229","ENSG00000167325","ENSG00000198056","ENSG00000100479","ENSG00000077514","ENSG00000106628","ENSG00000014138","ENSG00000175482"],"count":12},"linkedDiseases":{"rows":["EFO_0004708","EFO_0011061","EFO_0001075","EFO_0003859","EFO_1001958","MONDO_0003890","EFO_0000681","EFO_1000231","EFO_1001951","EFO_0000565","EFO_1001952","MONDO_0015760","EFO_0000588","EFO_0000096","MONDO_0002974","MONDO_0008903","EFO_1000251","MONDO_0005411","EFO_0008528","EFO_0001416","EFO_0002618","Orphanet_145","MONDO_0019465","EFO_0000466","MONDO_0021321","MONDO_0008170","EFO_1001973","MONDO_0004986","MONDO_0008627","MONDO_0008315","MONDO_0044791","EFO_1001959","MONDO_0002691","MONDO_0044889","EFO_0005537","EFO_0000574","EFO_0006544","EFO_1001051","EFO_0001378","EFO_1000613","EFO_1000624","EFO_1000172","EFO_1000412","MONDO_0004192","MONDO_0015686","MONDO_0007254","EFO_0004252","EFO_1001469","MONDO_0002087","EFO_0000305","MONDO_0020654","MONDO_0001187","MONDO_0001056","MONDO_0002158","EFO_1000044","EFO_1000043","EFO_1001974","EFO_0000183","EFO_1001963","EFO_0002914","EFO_0000616","EFO_0006859","EFO_1000314","EFO_0000313","EFO_0003060","EFO_0006738","EFO_1001961","EFO_0000311","HP_0001907","EFO_0000304","EFO_0006861","EFO_0006475","Orphanet_238510","EFO_0002517","MONDO_0011962","MONDO_0002367","EFO_0000691"],"count":77},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1996 and has 6 approved and 49 investigational indications."}
{"id":"CHEMBL165315","canonicalSmiles":"O=C(O)CCCCCn1c(C(=O)O)cc2cc(OCc3c(Cl)cccc3Cl)ccc21","inchiKey":"JTGPYFFQVOIJKR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL165315","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02316"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1673303","canonicalSmiles":"COc1cc(Cc2cnc(N)nc2N)c2c(c1OC)O[C@@H](C1CC1)C=C2","inchiKey":"HWJPWWYTGBZDEG-CQSZACIVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"(S)-ICLAPRIM","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["(S)-Iclaprim"],"crossReferences":{"drugbank":["DB07938"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL169526","canonicalSmiles":"CC(C)(C)COc1ccc(-n2cc(C(=O)O)cn2)cc1C#N","inchiKey":"AETHRPHBGJAIBT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL169526","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["137275979"],"drugbank":["DB03841"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1721885","canonicalSmiles":"Cc1[nH]c(/C=C2\\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1","inchiKey":"CTNPALGJUAXMMC-PMFHANACSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SU-014813","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["SU-14813","Su-014813","Su-14813"],"crossReferences":{"PubChem":["50100117"]},"linkedTargets":{"rows":["ENSG00000134853","ENSG00000128052","ENSG00000102755","ENSG00000037280","ENSG00000157404","ENSG00000113721","ENSG00000122025"],"count":7},"linkedDiseases":{"rows":["EFO_0000616","EFO_0003869"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL1743017","drugType":"Antibody","blackBoxWarning":false,"name":"FEZAKINUMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Fezakinumab","ILV-094"],"linkedTargets":{"rows":["ENSG00000127318"],"count":1},"linkedDiseases":{"rows":["EFO_0000685","EFO_0000676","EFO_0000274"],"count":3},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL1761322","canonicalSmiles":"CCS(=O)(=O)CCCC12CCC(c3nnc(-c4ccccc4C(F)(F)F)n3C)(CC1)CC2","inchiKey":"ORQZQBUNAMJFCY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MK-0736","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MK0736","Mk-0736","Mk0736"],"crossReferences":{"drugbank":["DB15209"]},"linkedTargets":{"rows":["ENSG00000117594"],"count":1},"linkedDiseases":{"rows":["EFO_0003875","EFO_0000537"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL182323","canonicalSmiles":"COc1cccc(Cn2c(C(=O)NC3CCN(C(C)C)CC3)cc3ccccc32)c1","inchiKey":"GIPCBGDQVGKMPO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL182323","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07973"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL185885","canonicalSmiles":"O=Cc1ccc(CO)o1","inchiKey":"NOEGNKMFWQHSLB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AES-103","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["5-(hydroxymethyl)-2-furaldehyde","5-(hydroxymethyl)-2-furfural","5-hydroxymethyl-2-furfuraldehyde","Aes-103","NSC-40738"],"crossReferences":{"PubChem":["144209090","144213856","17389229"],"Wikipedia":["Hydroxymethylfurfural"],"drugbank":["DB12298"],"chEBI":["412516"]},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL188921","canonicalSmiles":"COc1cc(OC)c(C(=O)CCCN2CCCC2)c(OC)c1","inchiKey":"OWYLAEYXIQKAOL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BUFLOMEDIL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Buflomedil"],"crossReferences":{"PubChem":["11112743","174006865","26757801"],"Wikipedia":["Buflomedil"],"drugbank":["DB13510"]},"childChemblIds":["CHEMBL1715107"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1923234","canonicalSmiles":"C[C@H](NC(=O)/C(C#N)=C/c1cccc(Br)n1)c1ccccc1","inchiKey":"VFUAJMPDXIRPKO-LQELWAHVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"WP 1066","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Wp 1066","Wp1066"],"crossReferences":{"drugbank":["DB12679"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1949708","canonicalSmiles":"Nc1nc(C(=O)N[C@H](CO)C(=O)O)c(N)nc1C(=O)N[C@H](CO)C(=O)O","inchiKey":"XHNJXRDGTITISI-QWWZWVQMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RELMAPIRAZIN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Lumitrace"],"synonyms":["MB-102","Mb-102","Relmapirazin"],"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL195660","canonicalSmiles":"CCSC[C@H]1O[C@@H](n2cnc3c(N)ncnc32)[C@H](O)[C@@H]1O","inchiKey":"HMXHURAGFHWODC-WOUKDFQISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL195660","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07052"],"chEBI":["74046"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL197672","canonicalSmiles":"C[C@H](NC(=O)C(=O)Nc1ccccc1C(C)(C)C)C(=O)N[C@@H](CC(=O)O)C(=O)COc1c(F)c(F)cc(F)c1F","inchiKey":"SCVHJVCATBPIHN-SJCJKPOMSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"EMRICASAN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Emricasan","IDN 6556","IDN-6556","PF 03491390","PF-03491390","VAY-785","VAY785"],"crossReferences":{"drugbank":["DB05408"]},"linkedTargets":{"rows":["ENSG00000164305","ENSG00000137757","ENSG00000064012","ENSG00000105141","ENSG00000196954","ENSG00000003400","ENSG00000132906","ENSG00000137752","ENSG00000106144","ENSG00000204403","ENSG00000138794","ENSG00000165806"],"count":12},"linkedDiseases":{"rows":["EFO_0001422","EFO_0004220","MONDO_0100096","EFO_0010282","EFO_0001421","EFO_1001249","EFO_1001345","EFO_0000400"],"count":8},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 8 investigational indications."}
{"id":"CHEMBL2023898","canonicalSmiles":"COC(=O)N[C@H](C(=O)N1CCC[C@H]1c1ncc(-c2ccc(-c3ccc(-c4cnc([C@@H]5CCCN5C(=O)[C@@H](NC(=O)OC)C(C)C)[nH]4)cc3)cc2)[nH]1)C(C)C","inchiKey":"FKRSSPOQAMALKA-CUPIEXAXSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"DACLATASVIR","yearOfFirstApproval":2015,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Daklinza"],"synonyms":["BMS 790052","BMS-790052","Daclatasvir","EBP 883","EBP-883"],"crossReferences":{"Wikipedia":["Daclatasvir"],"drugbank":["DB09102"],"chEBI":["82977"]},"childChemblIds":["CHEMBL2303621"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2015 and is indicated for viral disease and chronic hepatitis c virus infection and has 7 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL2103840","canonicalSmiles":"CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12","inchiKey":"PIMQWRZWLQKKBJ-SFHVURJKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DINACICLIB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Dinaciclib","Mk-7965","SCH 727965","SCH-727965"],"crossReferences":{"drugbank":["DB12021"]},"linkedTargets":{"rows":["ENSG00000164885","ENSG00000123374","ENSG00000136807","ENSG00000170312"],"count":4},"linkedDiseases":{"rows":["EFO_0000616","EFO_1000044","MONDO_0000544","EFO_0006861","EFO_0000095","MONDO_0001023","EFO_0000756","EFO_0000220","MONDO_0007254","EFO_0000222","EFO_0001378","MONDO_0023619","MONDO_0003865"],"count":13},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 9 investigational indications."}
{"id":"CHEMBL2104146","canonicalSmiles":"O=C([O-])O.O=S(=O)(O)c1cc(I)c(O)c2ncccc12.[Na+]","inchiKey":"FNXKBSAUKFCXIK-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"CHINIOFON","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1788402","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Chiniofon","NSC-758879"],"crossReferences":{"DrugCentral":["4362"],"drugbank":["DB13379"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2104927","canonicalSmiles":"CN(CCc1cc(C(F)(F)F)cc(C(F)(F)F)c1)C(=O)[C@H](c1ccccc1)N1CCN(CC2CC2)CC1","inchiKey":"HUTHJVYJUPXHDF-DEOSSOPVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FIGOPITANT","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BIIF 1149 BS","BIIF 1149 CL","BIIF-1149 BS","BIIF-1149-BS","Biif 1149","Figopitant"],"crossReferences":{"drugbank":["DB12122"]},"childChemblIds":["CHEMBL3542235"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2105036","canonicalSmiles":"O=C(O)Cn1cc(I)c(=O)c(I)c1.OCCNCCO","inchiKey":"RERHJVNYJKZHLJ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IODOPYRACET","maximumClinicalTrialPhase":0,"parentId":"CHEMBL2110615","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Diodrast"],"synonyms":["Cardiotrast","Diodone","Iodopyracet"],"crossReferences":{"DrugCentral":["4449"],"drugbank":["DB13568"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2105675","canonicalSmiles":"CNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.O=C(O)c1ccc2nc(-c3cc(Cl)cc(Cl)c3)oc2c1","inchiKey":"DQJDBUPLRMRBAB-WZTVWXICSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TAFAMIDIS MEGLUMINE","yearOfFirstApproval":2019,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL2103837","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Vyndaqel"],"synonyms":["FX-1006A","Tafamidis meglumine"],"crossReferences":{"DailyMed":["tafamidis%20meglumine"],"chEBI":["79345"]},"linkedTargets":{"rows":["ENSG00000118271"],"count":1},"linkedDiseases":{"rows":["EFO_0009562","EFO_0000318","EFO_1001875","Orphanet_271861","Orphanet_85447","Orphanet_85443"],"count":6},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2019 and has 3 approved and 2 investigational indications."}
{"id":"CHEMBL2106966","canonicalSmiles":"Cc1ccnc(NC(=O)C(C)c2cccc(C(=O)c3ccccc3)c2)c1","inchiKey":"ASFKKFRSMGBFRO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PIKETOPROFEN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Calmatel","Piketoprofen"],"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2107826","canonicalSmiles":"O=C(Nc1ccc(C[C@@H]2CC[C@H]([C@H](O)c3ccccc3)N2)cc1)[C@@H]1CCc2nccc(=O)n21","inchiKey":"DJXRIQMCROIRCZ-XOEOCAAJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VIBEGRON","yearOfFirstApproval":2020,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Gemtesa"],"synonyms":["KRP-114V","Mk4618","Vibegron"],"crossReferences":{"drugbank":["DB14895"]},"linkedTargets":{"rows":["ENSG00000188778"],"count":1},"linkedDiseases":{"rows":["EFO_0000555","EFO_0006865","HP_0000020","EFO_1000781","EFO_0000537"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2020 and has 3 approved and 2 investigational indications."}
{"id":"CHEMBL2107840","drugType":"Small molecule","blackBoxWarning":true,"name":"PATIROMER CALCIUM","yearOfFirstApproval":2015,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Veltassa"],"synonyms":["Patiromer calcium","Patiromer glucitol calcium","Patiromer sorbitex calcium","RLY-5016","RLY-5016S","RLY5016","RLY5016S"],"crossReferences":{"DailyMed":["patiromer%20sorbitex%20calcium"],"DrugCentral":["5056"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2015 and is indicated for hyperkalemia. This drug has a black box warning from the FDA."}
{"id":"CHEMBL2108057","drugType":"Antibody","blackBoxWarning":false,"name":"URTOXAZUMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["TMA-15","Urtoxazumab"],"description":"Antibody drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL2108660","drugType":"Antibody","blackBoxWarning":false,"name":"TUCOTUZUMAB CELMOLEUKIN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["EMD 273066","EMD-273066","HUKS-IL2","KSA-INTERLEUKIN-2","Tucotuzumab celmoleukin"],"linkedTargets":{"rows":["ENSG00000119888"],"count":1},"linkedDiseases":{"rows":["MONDO_0008170"],"count":1},"description":"Antibody drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL2108866","drugType":"Oligosaccharide","blackBoxWarning":false,"name":"STARCH","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Bio-sorb"],"synonyms":["Starch"],"description":"Oligosaccharide drug with a maximum clinical trial phase of IV (across all indications) and has 15 investigational indications."}
{"id":"CHEMBL2108887","drugType":"Antibody","blackBoxWarning":false,"name":"AFELIMOMAB","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Segard"],"synonyms":["Afelimomab","LU-54107","LU54107","MAK-195F"],"linkedTargets":{"rows":["ENSG00000232810"],"count":1},"linkedDiseases":{"rows":["EFO_0000540"],"count":1},"description":"Antibody drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2109177","drugType":"Antibody","blackBoxWarning":false,"name":"ODULIMOMAB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Afolimomab","Odulimomab","anti-LFA1"],"description":"Antibody drug with a maximum clinical trial phase of III."}
{"id":"CHEMBL2109673","drugType":"Unknown","blackBoxWarning":false,"name":"PTI-6D2 188RE","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["PTI-188","PTI-6D2","Pti-6d2 188re"],"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL211312","canonicalSmiles":"O=c1ccn([C@H]2C[C@H](O)[C@@H](COP(=O)(O)O)O2)c(=O)[nH]1","inchiKey":"JSRLJPSBLDHEIO-SHYZEUOFSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DEOXYURIDINE MONOPHOSPHATE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["2'-Deoxyuridinemonophosphate"],"crossReferences":{"Wikipedia":["Deoxyuridine_monophosphate"],"drugbank":["DB03800"],"chEBI":["17622"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL218382","canonicalSmiles":"COc1cc2c(cc1OS(N)(=O)=O)CC[C@@H]1[C@@H]2CC[C@]2(C)[C@@H](OS(N)(=O)=O)CC[C@@H]12","inchiKey":"AQSNIXKAKUZPSI-SSTWWWIQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL218382","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08416"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL219568","canonicalSmiles":"Nc1nc2[nH]cnc2c(=O)[nH]1","inchiKey":"UYTPUPDQBNUYGX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GUANINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["C.i. no. 75170 (guanine)","Ci 75170","Guanine","Valacyclovir hydrochloride, guanine-","Valganciclovir hydrochloride impurity b"],"crossReferences":{"Wikipedia":["Guanine"],"drugbank":["DB02377"],"chEBI":["16235"]},"childChemblIds":["CHEMBL1906087","CHEMBL2028459","CHEMBL141183"],"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 15 investigational indications."}
{"id":"CHEMBL222021","canonicalSmiles":"O=Cc1ccc(O)c(O)c1","inchiKey":"IBGBGRVKPALMCQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PROTOCATECHUALDEHYDE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["3,4-Dihydroxybenzaldehyde","Protocatechualdehyde"],"crossReferences":{"PubChem":["56422369","8139931"],"Wikipedia":["Protocatechuic_aldehyde"],"drugbank":["DB11268"],"chEBI":["50205"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2252949","canonicalSmiles":"CC1(C)[C@H]2CC[C@]1(C)C(=O)C2","inchiKey":"DSSYKIVIOFKYAU-OIBJUYFYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"(-)-CAMPHOR","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["251919659"],"drugbank":["DB11345"],"chEBI":["15397"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL229430","canonicalSmiles":"CC(=O)Nc1nc2c(Oc3cc(-c4ccc(C(F)(F)F)cc4)ncn3)cccc2s1","inchiKey":"YUTIXVXZQIQWGY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AMG-517","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AMG-517","Amg-517"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL230001","canonicalSmiles":"CO/C=C(/C(=O)OC)c1ccccc1Oc1cc(Oc2ccccc2C#N)ncn1","inchiKey":"WFDXOXNFNRHQEC-GHRIWEEISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AZOXYSTROBIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["DNDI1511705","TCMDC-125883"],"crossReferences":{"PubChem":["144214048","26757224"],"Wikipedia":["Azoxystrobin"],"drugbank":["DB07401"],"chEBI":["40909"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2346976","canonicalSmiles":"CC(=O)N1CCN(CCOc2ccc(C3CCN(C4=Nn5c(nnc5C(F)(F)F)CC4)CC3)cc2)CC1","inchiKey":"JMEYDSHPKCSIJC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AZD3514","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AZD-3514","Azd 3514","Azd3514","CS-1443"],"linkedTargets":{"rows":["ENSG00000169083"],"count":1},"linkedDiseases":{"rows":["MONDO_0008315"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL257468","canonicalSmiles":"O=C(Cc1cccs1)N[C@H](B(O)O)c1cccc(C(=O)O)c1","inchiKey":"HQLQTGGLHBYZSA-ZDUSSCGKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL257468","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08551"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL279115","canonicalSmiles":"CCCCCCCCCCCCCC(=O)O[C@@H]1[C@@H](C)[C@@]2(O)[C@@H](C=C(CO)C[C@]3(O)C(=O)C(C)=C[C@@H]23)[C@@H]2C(C)(C)[C@]12OC(C)=O","inchiKey":"PHEDXBVPIONUQT-RGYGYFBISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PHORBOL MYRISTATE ACETATE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["NSC-262244","Phorbol 12-myristate 13-acetate","Phorbol 12-myristate 13-acetate diester","Phorbol myristate acetate","Pma (phorbol ester)","Tetradecanoylphorbol acetate","Tpa (phorbol ester)"],"crossReferences":{"PubChem":["26755285"],"Wikipedia":["12-O-Tetradecanoylphorbol-13-acetate"],"chEBI":["37537"]},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL298445","canonicalSmiles":"Cc1nc(N)sc1-c1ccnc(Nc2cccc([N+](=O)[O-])c2)n1","inchiKey":"DYTKVFHLKPDNRW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL298445","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02833"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3039521","canonicalSmiles":"CC[C@]1(O)C[C@@H]2CN(CCc3c([nH]c4ccccc34)[C@@](C(=O)OC)(c3cc4c(cc3OC)N(C)[C@H]3[C@@](O)(C(=O)NNC(=O)OCCSSC[C@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@H](CC(=O)O)NC(=O)CC[C@H](NC(=O)c5ccc(NCc6cnc7[nH]c(N)nc(=O)c7n6)cc5)C(=O)O)C(=O)O)[C@H](O)[C@]5(CC)C=CCN6CC[C@]43[C@@H]65)C2)C1","inchiKey":"KUZYSQSABONDME-QRLOMCMNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VINTAFOLIDE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["EC-145","EC145","Vintafolide"],"crossReferences":{"drugbank":["DB05168"]},"linkedTargets":{"rows":["ENSG00000110195"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","EFO_0003869","EFO_0000571","MONDO_0008170","EFO_0003060","EFO_0000311"],"count":6},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 6 investigational indications."}
{"id":"CHEMBL3137693","drugType":"Small molecule","blackBoxWarning":false,"name":"GOLD","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Aurum metallicum","Ci 77480","Colloidal gold","E-175","Gold","Gold (e 175)","Gold, elemental","INS NO.175","INS-175"],"crossReferences":{"chEBI":["30050"]},"childChemblIds":["CHEMBL3833324"],"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL3181832","canonicalSmiles":"COc1cccc(OC)c1C(=O)N[C@@H]1C(=O)N2[C@@H](C(=O)[O-])C(C)(C)S[C@H]12.O.[Na+]","inchiKey":"NRZPASQBOYNGHR-HWROMZCQSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"METHICILLIN SODIUM","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL575","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Celbenin","Staphcillin"],"synonyms":["BRL-1241","Methicillin sodium","Methicillin sodium anhydrous","Meticillin sodium","Meticillin sodium monohydrate","NSC-757091","SQ 16,123","SQ-16123","Sodium methicillin","X-1497"],"crossReferences":{"PubChem":["144204873","170465152"],"chEBI":["34836"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982 and has 1 investigational indication."}
{"id":"CHEMBL338790","canonicalSmiles":"Nc1ccc2c3c(cccc13)C(=O)NC2=O","inchiKey":"SSMIFVHARFVINF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL338790","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["11110714","124879101","26753511","26753512","50105795","85230895","90340784"],"drugbank":["DB07096"],"chEBI":["40071"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL350239","canonicalSmiles":"CC(C)n1c(/C=C/[C@H](O)C[C@H](O)CC(=O)O)c(-c2ccc(F)cc2)c2ccccc21","inchiKey":"FJLGEFLZQAZZCD-JUFISIKESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL350239","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["26758026"],"drugbank":["DB01095"],"chEBI":["5136"]},"childChemblIds":["CHEMBL241778"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL353861","canonicalSmiles":"NS(=O)(=O)c1cc2c(s1)S(=O)(=O)N(c1cccc(O)c1)C(CN1CCOCC1)=C2","inchiKey":"PZLYYZPXSSNGJS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"AL-6619","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AL-6619"],"crossReferences":{"drugbank":["DB03262"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3545005","drugType":"Small molecule","blackBoxWarning":false,"name":"PLX-8394","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["PLX8394","Plx 8394","Plx-8394"],"linkedTargets":{"rows":["ENSG00000157764"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","EFO_1000956","MONDO_0002108","EFO_0000756","HP_0100727","EFO_0005221","EFO_0003060","EFO_1001951"],"count":8},"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 8 investigational indications."}
{"id":"CHEMBL3545025","drugType":"Small molecule","blackBoxWarning":false,"name":"INSM-18","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Insm-18"],"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL3545047","drugType":"Small molecule","blackBoxWarning":false,"name":"BMS-852927","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bms-852927","EXEL-04541041","XL-041","XL-652"],"linkedTargets":{"rows":["ENSG00000131408","ENSG00000025434"],"count":2},"linkedDiseases":{"rows":["HP_0003124"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3545096","canonicalSmiles":"COc1ccc(-c2ccc3ncc4c(c3c2)n(-c2ccc(N3CCNCC3)c(C(F)(F)F)c2)c(=O)n4C)cn1.O=C(O)/C=C\\C(=O)O","inchiKey":"YUXMAKUNSXIEKN-BTJKTKAUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BGT-226","maximumClinicalTrialPhase":2,"parentId":"CHEMBL3218578","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BGT226","Bgt-226","NVP-BGT-226","NVP-BGT226"],"crossReferences":{"chEBI":["71953"]},"linkedTargets":{"rows":["ENSG00000145675","ENSG00000171608","ENSG00000105647","ENSG00000141506","ENSG00000051382","ENSG00000121879","ENSG00000105851","ENSG00000117461","ENSG00000198793"],"count":9},"linkedDiseases":{"rows":["Orphanet_201","MONDO_0007254","EFO_0000311"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL3545102","drugType":"Small molecule","blackBoxWarning":false,"name":"SB-773812","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GW773812","SB-737050-A","SB-773812","Sb-773812"],"linkedTargets":{"rows":["ENSG00000149295","ENSG00000102468"],"count":2},"linkedDiseases":{"rows":["MONDO_0005090"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3545103","drugType":"Small molecule","blackBoxWarning":false,"name":"AZD3199","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Azd3199"],"linkedTargets":{"rows":["ENSG00000169252"],"count":1},"linkedDiseases":{"rows":["EFO_0000684","MONDO_0004979","EFO_0000341"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL3545145","drugType":"Small molecule","blackBoxWarning":false,"name":"WX-554","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Wx-554"],"linkedTargets":{"rows":["ENSG00000126934","ENSG00000169032"],"count":2},"linkedDiseases":{"rows":["EFO_0000616"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3545185","canonicalSmiles":"O=C(/C=C\\n1cnc(-c2cc(C(F)(F)F)cc(C(F)(F)F)c2)n1)NNc1cnccn1","inchiKey":"DEVSOMFAQLZNKR-RJRFIUFISA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SELINEXOR","yearOfFirstApproval":2019,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Xpovio"],"synonyms":["KPT-330","Selinexor"],"crossReferences":{"DailyMed":["selinexor"],"drugbank":["DB11942"]},"linkedTargets":{"rows":["ENSG00000082898"],"count":1},"linkedDiseases":{"rows":["MONDO_0044903","EFO_0001075","MONDO_0015686","EFO_0000756","EFO_0000681","EFO_1001465","MONDO_0007254","EFO_1000657","EFO_0000708","EFO_0000305","EFO_0003085","Orphanet_85443","EFO_1001480","EFO_1001459","EFO_0000339","EFO_0000096","MONDO_0019460","EFO_0000389","EFO_0000182","EFO_1000251","EFO_0008528","MONDO_0020743","EFO_0000707","MONDO_0002083","EFO_0002617","EFO_0000198","EFO_0000616","EFO_0000220","EFO_0001642","MONDO_0019457","EFO_0000403","EFO_0000222","EFO_1001968","EFO_0003060","MONDO_0008315","EFO_0000311","EFO_0000211","EFO_1000581","MONDO_0100096","MONDO_0011962","EFO_0004142","EFO_0000702","EFO_0000574","EFO_0001378","EFO_0000691","EFO_0000519"],"count":46},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2019 and has 4 approved and 35 investigational indications."}
{"id":"CHEMBL3545238","drugType":"Small molecule","blackBoxWarning":false,"name":"CS-8080","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cs-8080"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3545312","canonicalSmiles":"COC(=O)N[C@H](C(=O)N1CCC[C@H]1c1nc(-c2ccc3cc(-c4ccc5[nH]c([C@@H]6CCCN6C(=O)[C@@H](NC(=O)OC)C(C)C)nc5c4)ccc3c2)c[nH]1)C(C)C.Cl.Cl","inchiKey":"JYLMWUZJMRNMDA-SPRBZRACSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RAVIDASVIR HYDROCHLORIDE","maximumClinicalTrialPhase":2,"parentId":"CHEMBL3121849","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["BI 238630 CL2","BI-238630-CL2","BL-238630 DIHYDROCHLORIDE","PPI-668","Ravidasvir dihydrochloride","Ravidasvir hydrochloride"],"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3545340","canonicalSmiles":"CNC(=O)COc1cccc(Nc2ncc(F)c(Nc3ccc4c(c3)NC(=O)C(F)(F)O4)n2)c1.O=C(O)c1ccc2ccccc2c1O","inchiKey":"ILIHENOWEIBEQV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"R-343","maximumClinicalTrialPhase":2,"parentId":"CHEMBL2170582","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["R-343"],"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL3545415","drugType":"Protein","blackBoxWarning":false,"name":"SMC021","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Smc021"],"linkedTargets":{"rows":["ENSG00000004948"],"count":1},"linkedDiseases":{"rows":["EFO_0003854","EFO_0003882","MONDO_0005178","EFO_0003922"],"count":4},"description":"Protein drug with a maximum clinical trial phase of III (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL356359","canonicalSmiles":"CCCCN1CCC(CNC(=O)c2c3n(c4ccccc24)CCCO3)CC1","inchiKey":"KVCSJPATKXABRQ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PIBOSEROD","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Piboserod","SB-207266"],"crossReferences":{"PubChem":["137275879"],"Wikipedia":["Piboserod"],"drugbank":["DB04873"]},"childChemblIds":["CHEMBL2106927"],"linkedTargets":{"rows":["ENSG00000164270"],"count":1},"linkedDiseases":{"rows":["EFO_0000275","EFO_0000373"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL363648","canonicalSmiles":"CCc1nc(-c2cccc(C)c2)c(-c2ccnc(NC(=O)c3ccccc3)c2)s1","inchiKey":"HEKAIDKUDLCBRU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TAK-715","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["TAK 715","TAK-715","Tak-715"],"crossReferences":{"PubChem":["103905024","174006984"]},"linkedTargets":{"rows":["ENSG00000112062"],"count":1},"linkedDiseases":{"rows":["EFO_0000685"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL3707249","drugType":"Small molecule","blackBoxWarning":false,"name":"ASM-024","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Asm-024"],"linkedTargets":{"rows":["ENSG00000175344","ENSG00000133019","ENSG00000080644","ENSG00000168539","ENSG00000117971","ENSG00000181072"],"count":6},"linkedDiseases":{"rows":["MONDO_0004979","EFO_0000341","MONDO_0004784"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL3707258","canonicalSmiles":"OC(CI)CI","inchiKey":"DNKPFCQEGBJJTE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIIODOHYDROXYPROPANE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Diiodohydroxypropane"],"crossReferences":{"drugbank":["DB13383"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL385587","canonicalSmiles":"C[C@@H](C(=O)N1CCOCC1)N1CC[C@H](NS(=O)(=O)c2ccc3cc(Cl)ccc3c2)C1=O","inchiKey":"ICLOZQFWTRAYPX-LIRRHRJNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL385587","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07847"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL385711","canonicalSmiles":"C[C@@H]1C(=O)NCCCN1C(=O)C[C@H](N)Cc1cc(F)c(F)cc1F","inchiKey":"SWKGZJAAGSVROJ-MWLCHTKSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL385711","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07154"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3989522","canonicalSmiles":"O.O=C([O-])CN(CCN(CC(=O)[O-])CC(=O)[O-])CC(=O)[O-].[Ca+2].[Na+].[Na+]","inchiKey":"JHECKPXUCKQCSH-UHFFFAOYSA-J","drugType":"Small molecule","blackBoxWarning":true,"name":"EDETATE CALCIUM DISODIUM","yearOfFirstApproval":1953,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1200375","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Calcium Disodium Edetate","Calcium Disodium Edta","Calcium Edetate Sodium","Calcium Edta","Calcium disodium versenate","Edta Calcium Disodium","Edthamil","Ledclair","Sodium Calcium Edetate","Sodium Calciumedetate","Versene Ca"],"synonyms":["Adsorbonac","Antallin","Calcium disodium edetate","Calcium disodium edta dihydrate","Calcium sodium edetate hydrate","Calcium tetracemine disodium","Calcium titriplex","Calciumedetate sodium","Detoxamin","Disodium calcium edta","E-385","Edathamil","Edetamine","Edetate calcium disodium","Edta calcium","Edta calcium disodium salt","INS NO.385","INS-385","Mosatil","NSC-310151","Natrii calcii edetas","Sodium calcium edetate","Sodium calciumedetate","Sormetal","Tetazine"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1953 and is indicated for heavy metal poisoning. This drug has a black box warning from the FDA."}
{"id":"CHEMBL3989571","canonicalSmiles":"CN[C@H]1[C@@H](O)[C@@H](NC)[C@H](O)[C@H]2O[C@@H]3O[C@H](C)CC(=O)[C@]3(O)O[C@H]12.Cl.Cl.O.O.O.O.O","inchiKey":"DCHJOVNPPSBWHK-UXXUFHFZSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SPECTINOMYCIN HYDROCHLORIDE","yearOfFirstApproval":1971,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1167","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Actinospectacin","Espectinomicina","Spectam","Stanilo","Trobicin"],"synonyms":["M-141","NSC-248616","NSC-757319","Spectinomycin dihydrochloride","Spectinomycin hcl","Spectinomycin hcl pentahydrate","Spectinomycin hydrochloride","Spectinomycini hydrochloridum","U-18,409AE","U-18409AE"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1971."}
{"id":"CHEMBL3989766","canonicalSmiles":"CN[C@H](CC(C)C)C(=O)N[C@H]1C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]2C(=O)N[C@H]3C(=O)N[C@H](C(=O)N[C@H](C(=O)O)c4cc(O)cc(O)c4-c4cc3ccc4O)[C@H](O[C@H]3C[C@](C)(N)[C@@H](O)[C@H](C)O3)c3ccc(c(Cl)c3)Oc3cc2cc(c3O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O[C@H]2C[C@](C)(NCc3ccc(-c4ccc(Cl)cc4)cc3)[C@@H](O)[C@H](C)O2)Oc2ccc(cc2Cl)[C@H]1O.O=P(O)(O)O.O=P(O)(O)O","inchiKey":"PWTROOMOPLCZHB-BHYQHFGMSA-N","drugType":"Unknown","blackBoxWarning":false,"name":"ORITAVANCIN DIPHOSPHATE","yearOfFirstApproval":2014,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1688530","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Kimyrsa","Orbactiv"],"synonyms":["LY-333328 DIPHOSPHATE","LY333328 DIPHOSPHATE","Nuvocid","Oritavancin diphosphate","Oritavancin phosphate"],"crossReferences":{"DailyMed":["oritavancin%20diphosphate"]},"description":"Unknown drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2014 and is indicated for infection and has 4 investigational indications."}
{"id":"CHEMBL3989990","drugType":"Antibody","blackBoxWarning":false,"name":"ISTIRATUMAB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Istiratumab","MM-005","MM-141"],"linkedTargets":{"rows":["ENSG00000065361","ENSG00000140443"],"count":2},"linkedDiseases":{"rows":["EFO_0002618","EFO_0000182"],"count":2},"description":"Antibody drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL401974","canonicalSmiles":"CC(C)CCn1c(=O)c(C2=Nc3ccc(NS(C)(=O)=O)cc3S(=O)(=O)N2)c(O)c2cccn21","inchiKey":"FTVCONULIKITPZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL401974","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07062"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL411084","canonicalSmiles":"CN(C)C[C@H](O)Cn1c2ccc(Br)cc2c2cc(Br)ccc21","inchiKey":"XUBJEDZHBUPBKL-ZDUSSCGKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"WISKOSTATIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB01731"],"chEBI":["78011"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4228250","canonicalSmiles":"CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@@H](N)CCCCN)C(=O)N[C@@H](Cc1cnc[nH]1)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCNC(=N)N)C(=O)O)C(C)C","inchiKey":"LGANPTNILMNMES-TVNHODDRSA-N","drugType":"Protein","blackBoxWarning":false,"name":"SOR-C13","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Sor-c13"],"crossReferences":{"drugbank":["DB15366"]},"description":"Protein drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4280766","canonicalSmiles":"CC(=O)N[C@H]1[C@@H](O[C@@H]2C(C(=O)O)O[C@@H](O[C@@H]3[C@@H](CO)O[C@H](O[C@@H](CO)C(O[C@H](O)CO)C(=O)O)[C@H](NC(C)=O)[C@H]3O)[C@H](OS(=O)(=O)O)[C@H]2O)O[C@H](CO)[C@@H](O)[C@@H]1O","inchiKey":"YUQCJZVVMQZBFE-JPUFUMQZSA-N","drugType":"Oligosaccharide","blackBoxWarning":false,"name":"RONEPARSTAT","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Roneparstat"],"description":"Oligosaccharide drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4297414","canonicalSmiles":"COC(=O)C[C@@]1(CN)C[C@@H]2CC[C@@H]2C1","inchiKey":"ASBDKEXHKWHAPE-JZYVYDRUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PD-217014","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Pd-217,014","Pd-217014"],"crossReferences":{"drugbank":["DB12493"]},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297519","canonicalSmiles":"CC[C@H]1OC(=O)[C@H](C)C(=O)[C@H](C)[C@@H](O[C@@H]2O[C@H](C)C[C@H](N(C)C)[C@H]2O)[C@](C)(OC)C[C@@H](C)C(=O)[C@H](C)[C@H]2[C@H](/C(N)=N/O[C@@H](C)c3nnc(-c4ccccn4)s3)C(=O)O[C@@]21C","inchiKey":"RLFCSBSRGRJFRO-QAOQTAGDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NAFITHROMYCIN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Nafithromycin"],"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4297774","drugType":"Antibody","blackBoxWarning":false,"name":"AMIVANTAMAB","yearOfFirstApproval":2021,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Rybrevant"],"synonyms":["Amivantamab","Amivantamab-vmjw","CNTO-4424","CNTO4424","JNJ 61186372","JNJ-611","JNJ-61186372","JNJ-6372","Jnj 61186372","Jnj-61186372"],"linkedTargets":{"rows":["ENSG00000146648","ENSG00000105976"],"count":2},"linkedDiseases":{"rows":["MONDO_0001056","MONDO_0004669","EFO_0003060"],"count":3},"description":"Antibody drug with a maximum clinical trial phase of IV that was first approved in 2021 and is indicated for non-small cell lung carcinoma."}
{"id":"CHEMBL4297785","drugType":"Antibody","blackBoxWarning":false,"name":"VIBOSTOLIMAB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["MK-7684","MK7684","Mk-7684","TIGIT INHIBITOR MK-7684","TIGIT-TARGETING AGENT MK-7684","Vibostolimab"],"linkedTargets":{"rows":["ENSG00000181847"],"count":1},"linkedDiseases":{"rows":["EFO_0000616","EFO_0001642","EFO_0000756","EFO_0000702","EFO_0003060","MONDO_0008315","EFO_1001951"],"count":7},"description":"Antibody drug with a maximum clinical trial phase of III (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL4297880","drugType":"Protein","blackBoxWarning":false,"name":"EVORPACEPT","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ALX-148","ALX148","Alx 148","Alx-148","Alx148","Evorpacept","Lggl-alx-148","Sirpa variant alx148"],"description":"Protein drug with a maximum clinical trial phase of II (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL4302505","canonicalSmiles":"CC(C)CCNc1ncccc1C(=O)N1CCN(Cc2ccccc2)CC1","inchiKey":"DYTOQURYRYYNOR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NSI-189","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Nsi-189"],"childChemblIds":["CHEMBL4297309"],"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL436784","canonicalSmiles":"O=c1cc(C(F)(F)F)c2cc(N(CC(F)(F)F)CC(F)(F)F)ccc2[nH]1","inchiKey":"ULBPQWIGZUGPHU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"LGD-2226","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["LGD-2226"],"crossReferences":{"drugbank":["DB08089"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL447861","canonicalSmiles":"O=C(OCc1ccccc1)c1ccc(O)cc1","inchiKey":"MOZDKDIOPSPTBH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"4-Hydroxy Benzoic Acid Benzyl Ester","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["4-Hydroxy Benzoic Acid Benzyl Ester"],"crossReferences":{"PubChem":["144205641","144212647","170465711","26757572"],"drugbank":["DB14176"],"chEBI":["34571"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL45068","canonicalSmiles":"O=C(CCc1ccc(O)cc1)c1c(O)cc(O)cc1O","inchiKey":"VGEREEWJJVICBM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PHLORETIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["2',4,4',6'-Tetrahydroxy-Dihydrochalcone","2',4,4',6'-Tetrahydroxydihydrochalcone","Phloretin"],"crossReferences":{"PubChem":["11111666","11111667","124881191","124881192","124881194","144210052","174006856","26725279","26747651","26753632","46500461","50106910","50106911","85231195","90341086"],"drugbank":["DB07810"],"chEBI":["17276"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4524066","canonicalSmiles":"CCCCCCCCCCCCCCCC(=O)N[C@@H](CCC(O)NCCCC[C@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](C)NC(=O)[C@@H](N)Cc1c[nH]cn1)[C@@H](C)O)[C@@H](C)O)C(C)C)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@H](C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CC(C)C)C(=O)N[C@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(=O)O)C(C)C)[C@@H](C)CC)C(=O)O","inchiKey":"VXEVKSKAINMPFG-QWUNSSNDSA-N","drugType":"Protein","blackBoxWarning":true,"name":"LIRAGLUTIDE","yearOfFirstApproval":2010,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Saxenda","Victoza"],"synonyms":["Liraglutide","Liraglutide (rdna origin)","Liraglutide recombinant","NN-2211","NN-9924","NN2211","NN9924","NNC 90-1170","NNC-90-1170"],"crossReferences":{"DailyMed":["liraglutide","liraglutide%20recombinant"]},"linkedTargets":{"rows":["ENSG00000112164"],"count":1},"linkedDiseases":{"rows":["EFO_0003095","MONDO_0002009","EFO_0000275","EFO_0000401","EFO_1001249","HP_0001824","EFO_0005924","EFO_0000289","EFO_0004593","MONDO_0005180","EFO_0003144","MONDO_0015183","EFO_0004616","EFO_0000400","EFO_0002546","EFO_0003877","EFO_0003921","EFO_0004319","EFO_0005203","EFO_0001074","HP_0002024","EFO_0001073","EFO_0000195","EFO_1001121","EFO_0002614","MONDO_0005147","Orphanet_552","MONDO_0004975","HP_0003074","EFO_0000341","EFO_0005611","MONDO_0005148"],"count":32},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2010 and has 3 approved and 20 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL457047","canonicalSmiles":"NS(=O)(=O)c1cccc2c(O)cccc12","inchiKey":"NFVBVKHGDDDCEA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL457047","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08132"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL46148","canonicalSmiles":"N=C(N)c1ccc2[nH]c(Cc3nc4ccccc4[nH]3)nc2c1","inchiKey":"KKJYVDXDZURHMA-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL46148","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB01767"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4650300","canonicalSmiles":"CCCCCCCC/C=C\\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCNC(=O)CCCCC(=O)NCCCO[C@@H]1O[C@H](CO)[C@@H](O[C@@H]2O[C@H](CO)[C@H](O)[C@H](O[C@H]3O[C@H](CO)[C@H](O)[C@H](O)[C@H]3O)[C@H]2O)[C@H](O)[C@H]1NC(C)=O)OC(=O)CCCCCCC/C=C\\CCCCCCCC","inchiKey":"ZJYQGJWRGLACDM-UNBAAJOISA-N","drugType":"Oligosaccharide","blackBoxWarning":false,"name":"AGI-134","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AGI-134","AGI134","Agi-134"],"description":"Oligosaccharide drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4650743","canonicalSmiles":"C[N+](C)(C)CCOC(=O)CCCC[C@@H]1CCSS1","inchiKey":"BJNSJJXGLIMYAJ-GFCCVEGCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":".ALPHA.-R-LIPOIC ACID CHOLINE ESTER","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"childChemblIds":["CHEMBL4650363"],"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL466659","canonicalSmiles":"O=[N+]([O-])OCC(CO[N+](=O)[O-])(CO[N+](=O)[O-])CO[N+](=O)[O-]","inchiKey":"TZRXHJWUDPFEEY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PENTAERYTHRITOL TETRANITRATE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cardiacap","Mycardol","Pentritol tempules","Peritrate","Peritrate sa"],"synonyms":["Pentaerithritol tetranitrate","Pentaerithrityl tetranitrate","Pentaerythritol tetranitrate","Pentaerythrityl tetranitrate","Pentalong","Pentanitrol"],"crossReferences":{"PubChem":["144205177","144212064","29215318"],"Wikipedia":["Pentaerythritol_tetranitrate"],"drugbank":["DB06154"],"chEBI":["25879"]},"linkedTargets":{"rows":["ENSG00000164116","ENSG00000061918","ENSG00000123201","ENSG00000152402"],"count":4},"linkedDiseases":{"rows":["EFO_0000319"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for cardiovascular disease."}
{"id":"CHEMBL468","canonicalSmiles":"O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1","inchiKey":"UEJJHQNACJXSKW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"THALIDOMIDE","yearOfFirstApproval":1998,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Talidex","Thalomid"],"synonyms":[".alpha.-phthalimidoglutarimide","Celgene","Contergan","Distaval","K-17","Myrin","N-phthalylglutamic acid imide","NSC-527179","NSC-66847","Neurosedyn","Pantosediv","Pharmion","Softenon","Thaled","Thalidomide","Thalidomide "],"crossReferences":{"DailyMed":["thalidomide"],"PubChem":["111716","11532929","124881523","144210897","170465323","174007312","26747126","26751823","50104514","90341724"],"Wikipedia":["Thalidomide"],"drugbank":["DB01041"],"chEBI":["74947"]},"linkedTargets":{"rows":["ENSG00000139842","ENSG00000113851","ENSG00000167986","ENSG00000100387"],"count":4},"linkedDiseases":{"rows":["EFO_0000729","EFO_1000403","EFO_0005543","EFO_0000365","HP_0012735","EFO_0000756","EFO_0000681","Orphanet_848","EFO_0005952","EFO_0000540","HP_0003073","Orphanet_85443","EFO_1001951","EFO_0000565","EFO_0007312","EFO_0007160","EFO_1000318","EFO_0000096","EFO_0002690","EFO_0000389","MONDO_0008903","EFO_0000182","EFO_0000676","MONDO_0004976","EFO_1000045","EFO_0009441","EFO_0000198","MONDO_0008170","EFO_0002939","EFO_1001968","EFO_0000384","MONDO_0008315","Orphanet_398934","MONDO_0002691","EFO_1001231","MONDO_0100096","MONDO_0019472","EFO_0000574","EFO_1000613","EFO_0001378","EFO_0000342","MONDO_0015564","Orphanet_314701","MONDO_0044903","EFO_1001984","EFO_1001901","EFO_0001065","EFO_0000768","MONDO_0007254","MONDO_0003196","EFO_0000373","EFO_1001469","MONDO_0021063","MONDO_0002087","EFO_0002430","MONDO_0001056","EFO_1001480","MONDO_0002158","EFO_0000474","EFO_0006888","EFO_1001974","EFO_1001996","EFO_0000673","EFO_0000326","EFO_0000183","EFO_0003047","EFO_0000717","EFO_1000158","EFO_0005628","Orphanet_797","EFO_0000616","EFO_0000765","EFO_0006859","EFO_0008572","EFO_0001645","EFO_0000403","EFO_0003898","MONDO_0007576","EFO_1001875","MONDO_0019558","EFO_0003843","EFO_0003060","EFO_0000621","EFO_0000311","EFO_0003834","EFO_0005570","EFO_0003865","EFO_0004268","EFO_0000095","EFO_1001767","EFO_0000764","MONDO_0004975","EFO_0004142","EFO_0000191","MONDO_0002367","MONDO_0018906","EFO_0000691","EFO_0000519"],"count":98},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1998 and is indicated for multiple myeloma and immune system disease and has 84 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL469912","canonicalSmiles":"COc1ccc(C[C@H](N)C(=O)N[C@@H]2[C@@H](CO)O[C@@H](n3cnc4c(N(C)C)ncnc43)[C@@H]2O)cc1","inchiKey":"RXWNCPJZOCPEPQ-NVWDDTSBSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PUROMYCIN","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["3123-L","3123L","CL 13,900","CL-13900","GNF-PF-2016","P-638","Puromycin","TCMDC-123493"],"crossReferences":{"drugbank":["DB08437"],"chEBI":["17939"]},"childChemblIds":["CHEMBL531268","CHEMBL2104870"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL471737","canonicalSmiles":"COc1cc2c(cc1OC)CC(=O)N(CCCN(C)C[C@H]1Cc3cc(OC)c(OC)cc31)CC2","inchiKey":"ACRHBAYQBXXRTO-OAQYLSRUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"IVABRADINE","yearOfFirstApproval":2015,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Corlanor","Procoralan"],"synonyms":["Ivabradine","S-16257"],"crossReferences":{"DailyMed":["ivabradine","ivabradine%20hydrochloride"],"PubChem":["50125937"],"Wikipedia":["Ivabradine"],"drugbank":["DB09083"],"chEBI":["85966"]},"childChemblIds":["CHEMBL2145077"],"linkedTargets":{"rows":["ENSG00000138622"],"count":1},"linkedDiseases":{"rows":["EFO_0007372","EFO_1000899","HP_0001649","EFO_0006834","EFO_0000275","EFO_0001645","EFO_0000401","EFO_0005252","EFO_0000373","EFO_0000319","EFO_0000311","EFO_0003913","GO_0007568","EFO_0003144","EFO_0000574","EFO_1001373","EFO_1001207","EFO_0000341","HP_0031273","EFO_0005672","EFO_0008586","EFO_0005251"],"count":22},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2015 and has 3 approved and 18 investigational indications."}
{"id":"CHEMBL478718","canonicalSmiles":"NCCCC(=O)Nc1ccc(OCc2ccccc2)cc1","inchiKey":"QTWBKNVNGVYTNZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL478718","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07104"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL480411","canonicalSmiles":"CC(C)(C)NS(=O)(=O)c1ccc(-c2ccc3[nH]nc(N)c3c2)cc1","inchiKey":"KFJCXIOVAGJCKB-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL480411","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07162"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL489157","canonicalSmiles":"NCCNS(=O)(=O)c1ccc(Cl)c2ccncc12","inchiKey":"OGKYMFFYOWUTKV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL489157","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03693"],"chEBI":["47322"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL521851","canonicalSmiles":"CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1","inchiKey":"LHNIIDJUOCFXAP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PICTILISIB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CDC-0941","GDC 0941","GDC-0941","Pictilisib","Pictrelisib","Rg-7321"],"crossReferences":{"PubChem":["103905592"],"drugbank":["DB11663"],"chEBI":["65326"]},"childChemblIds":["CHEMBL4097197","CHEMBL1922096"],"linkedTargets":{"rows":["ENSG00000145675","ENSG00000171608","ENSG00000105647","ENSG00000141506","ENSG00000051382","ENSG00000121879","ENSG00000105851","ENSG00000117461"],"count":8},"linkedDiseases":{"rows":["EFO_0000616","MONDO_0007254","EFO_0005952","EFO_0003060","EFO_0000311"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL524","canonicalSmiles":"COc1ccc(OC)c(C(O)C(C)N)c1","inchiKey":"WJAJPNHVVFWKKL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"METHOXAMINE","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Methoxamine","NRL-001","NRL001","Nrl001","Vasoxyl"],"crossReferences":{"PubChem":["90341132"],"Wikipedia":["Methoxamine"],"drugbank":["DB00723"],"chEBI":["6839"]},"childChemblIds":["CHEMBL1201103"],"linkedTargets":{"rows":["ENSG00000171873","ENSG00000170214","ENSG00000120907"],"count":3},"linkedDiseases":{"rows":["HP_0000020","EFO_0000319","EFO_0009523"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1982 and is indicated for cardiovascular disease and has 3 investigational indications."}
{"id":"CHEMBL551043","canonicalSmiles":"Cc1csc(NC(=O)c2nc(Sc3nncn3C)ccc2Sc2ccc(F)cc2)n1","inchiKey":"SJTQKYKXCYVFHX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL551043","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07359"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL57531","canonicalSmiles":"Nc1ncc2cc(-c3c(Br)cccc3Br)c(N)nc2n1","inchiKey":"HGIPWJYTPOHUGK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL57531","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08144"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL578211","canonicalSmiles":"CN1C(=O)CC[C@H]1c1cccnc1","inchiKey":"UIKROCXWUNQSPJ-VIFPVBQESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"COTININE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cotinine","Nicotine related compound c"],"crossReferences":{"PubChem":["144204770","170466160","26753539","50106041","50106042","50106043","50106044","90341278"],"Wikipedia":["Cotinine"],"chEBI":["68641"]},"childChemblIds":["CHEMBL3989573"],"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL579205","canonicalSmiles":"CNc1ccc(-c2nc3ccc(O)cc3s2)cc1F","inchiKey":"VVECGOCJFKTUAX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FLUTEMETAMOL","yearOfFirstApproval":2013,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Flutemetamol","[3H]-Flutemetamol"],"crossReferences":{"DailyMed":["flutemetamol%20f-18"],"drugbank":["DB15058"]},"childChemblIds":["CHEMBL2042122"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2013 and is indicated for cognitive impairment and alzheimer disease and has 1 investigational indication."}
{"id":"CHEMBL604608","canonicalSmiles":"OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O","inchiKey":"RFSUNEUAIZKAJO-ARQDHWQXSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FRUCTOSE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Dietade dietary foods"],"synonyms":["D-fructose","Fructose","Levulose","NSC-760385","NSC-9250","Nevulose","Sugar fruit fine","Topiramate impurity, fructose-"],"crossReferences":{"PubChem":["144207106","144207960"],"Wikipedia":["Fructose"],"chEBI":["28645"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL72006","canonicalSmiles":"CC(C)C[C@H](NC(=O)OCc1ccccc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)CF","inchiKey":"JCRSHQCFRMCMOC-GSDHBNRESA-N","drugType":"Protein","blackBoxWarning":false,"name":"CHEMBL72006","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04653"]},"description":"Protein drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL8260","canonicalSmiles":"O=c1cc(-c2ccccc2)oc2cc(O)c(O)c(O)c12","inchiKey":"FXNFHKRTJBSTCS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BAICALEIN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Baicalein","NSC-661431","Noroxylin"],"crossReferences":{"PubChem":["11113153","11114203","124882850","124882851","124882853","26747176","50104952","85272355"],"Wikipedia":["Baicalein"],"chEBI":["2979"]},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL850","canonicalSmiles":"C[C@H]1CN(c2c(F)c(N)c3c(=O)c(C(=O)O)cn(C4CC4)c3c2F)C[C@@H](C)N1","inchiKey":"DZZWHBIBMUVIIW-DTORHVGOSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SPARFLOXACIN","yearOfFirstApproval":1996,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["United States"],"classes":["Cardiotoxicity"," Dermatological toxicity"],"year":2001},"tradeNames":["Spara","Zagam"],"synonyms":["AT-4140","CI-978","NSC-759641","Sparfloxacin"],"crossReferences":{"PubChem":["144205133","26719819","29218052"],"Wikipedia":["Sparfloxacin"],"drugbank":["DB01208"],"chEBI":["9212"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1996 and is indicated for bacterial disease and has 1 investigational indication. It was withdrawn in United States  in 2001 due to Cardiotoxicity and  Dermatological toxicity."}
{"id":"CHEMBL852","canonicalSmiles":"N[C@@H](Cc1ccc(N(CCCl)CCCl)cc1)C(=O)O","inchiKey":"SGDBTWWWUNNDEQ-LBPRGKRZSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"MELPHALAN","yearOfFirstApproval":1964,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Aikeran","Alkeran"],"synonyms":["Alanine nitrogen mustard","CB 3025","CB-3025","L-pam","L-phenylalanine mustard","L-sarcolysin","Melfalan","Melphalan","NCI-C04853","NSC-241286","NSC-8806","Phenylalanine mustard","SK 15673","SK-15673","Sarcolycin, l-"],"crossReferences":{"DailyMed":["melphalan","melphalan%20hydrochloride"],"PubChem":["144204561","144209720","170464727","17389837","26752787","56463160"],"Wikipedia":["Melphalan"],"drugbank":["DB01042"],"chEBI":["28876"]},"childChemblIds":["CHEMBL1200863"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1964 and has 4 approved and 103 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL888","canonicalSmiles":"Nc1ccn([C@@H]2O[C@H](CO)[C@@H](O)C2(F)F)c(=O)n1","inchiKey":"SDUQYLNIPVEERB-QPPQHZFASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GEMCITABINE","yearOfFirstApproval":1996,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Gemzar"],"synonyms":["Gemcitabine","Gemzar","LY-188011","LY188011","NSC-613327"],"crossReferences":{"DailyMed":["gemcitabine%20hydrochloride"],"PubChem":["124893555","50113286"],"Wikipedia":["Gemcitabine"],"drugbank":["DB00441"],"chEBI":["175901"]},"childChemblIds":["CHEMBL1637"],"linkedTargets":{"rows":["ENSG00000177084","ENSG00000101868","ENSG00000062822","ENSG00000146143","ENSG00000148229","ENSG00000167325","ENSG00000198056","ENSG00000100479","ENSG00000077514","ENSG00000106628","ENSG00000014138","ENSG00000175482"],"count":12},"linkedDiseases":{"rows":["EFO_0003891","EFO_0004708","EFO_0000637","EFO_0000365","EFO_0003859","EFO_0011061","EFO_0000756","EFO_0000681","EFO_1000231","EFO_0005952","EFO_1001951","EFO_1001952","MONDO_0015760","MONDO_0003059","EFO_0000588","EFO_0000096","EFO_0000564","MONDO_0002974","MONDO_0008903","EFO_1000251","EFO_0008528","EFO_0000514","EFO_0004606","MONDO_0021054","EFO_0009534","EFO_0002618","MONDO_0019465","EFO_1001973","EFO_1001968","MONDO_0004986","MONDO_0008627","EFO_0005221","MONDO_0008315","EFO_1000026","MONDO_0002691","Orphanet_398934","EFO_0003032","MONDO_0044889","MONDO_0019472","EFO_0000574","EFO_0001378","EFO_0001376","EFO_1000412","MONDO_0021117","EFO_0002913","MONDO_0007254","EFO_0000255","EFO_0004252","MONDO_0020654","MONDO_0001056","MONDO_0002158","EFO_1001974","EFO_0000183","EFO_0000707","EFO_0000616","EFO_0005088","EFO_0006859","EFO_1000314","EFO_0000403","Orphanet_44890","MONDO_0007576","EFO_0000222","EFO_1001961","EFO_0000304","Orphanet_238510","EFO_0002517","MONDO_0011962","EFO_0000702","MONDO_0002367","MONDO_0018906","MONDO_0024880","MONDO_0003060","EFO_0003869","EFO_0001075","EFO_1001958","MONDO_0003890","EFO_0000571","EFO_1000657","EFO_0002426","EFO_0000228","EFO_0000565","EFO_0000182","MONDO_0005411","MONDO_0003000","EFO_0001416","Orphanet_145","EFO_0003893","EFO_1001956","EFO_1000292","EFO_0000220","MONDO_0021321","EFO_0000466","MONDO_0008170","MONDO_0002108","EFO_0005842","EFO_0002939","MONDO_0044791","EFO_1001959","EFO_0009708","EFO_0000294","EFO_0001061","EFO_1001100","EFO_0005537","EFO_0006544","EFO_1001051","EFO_1000613","EFO_1000624","MONDO_0009348","EFO_1000172","EFO_0006718","MONDO_0019471","MONDO_0004192","MONDO_0015686","EFO_0000708","MONDO_0021063","MONDO_0002087","EFO_1001469","MONDO_0024879","EFO_0000305","MONDO_0001187","EFO_1001480","EFO_1000044","EFO_1000043","EFO_1000218","EFO_0003860","EFO_0000770","MONDO_0001657","EFO_0005230","EFO_1001963","EFO_0002914","MONDO_0000430","EFO_0000478","EFO_0000313","EFO_0003060","EFO_0000311","EFO_0006738","EFO_0000211","HP_0001907","EFO_0003863","MONDO_0003572","EFO_0010282","EFO_0006861","EFO_0006475","EFO_0000174","MONDO_0003219","EFO_0003050","EFO_0000691","EFO_0000181"],"count":148},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1996 and has 8 approved and 128 investigational indications."}
{"id":"CHEMBL900","canonicalSmiles":"Cc1ccccc1C(OCCN(C)C)c1ccccc1","inchiKey":"QVYRGXJJSLMXQH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ORPHENADRINE","yearOfFirstApproval":1957,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Disipal","Invagesic","Mefenamine","Mialgin","Norflex","Norgesic","Orphenadrin","Orphenadrine","Orphengesic"],"crossReferences":{"DailyMed":["orphenadrine%20citrate"],"PubChem":["124880989","174006927","90341796"],"Wikipedia":["Orphenadrine"],"drugbank":["DB01173"],"chEBI":["7789"]},"childChemblIds":["CHEMBL1201023","CHEMBL1200395"],"linkedTargets":{"rows":["ENSG00000183454","ENSG00000273079","ENSG00000116032","ENSG00000103546","ENSG00000136546","ENSG00000198785","ENSG00000168356","ENSG00000007314","ENSG00000196876","ENSG00000185313","ENSG00000161509","ENSG00000183873","ENSG00000144285","ENSG00000105464","ENSG00000169432","ENSG00000176884","ENSG00000196639","ENSG00000136531","ENSG00000153253"],"count":19},"linkedDiseases":{"rows":["MONDO_0005180","HP_0003419","EFO_0003843"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1957 and is indicated for pain and parkinson disease and has 1 investigational indication."}
{"id":"CHEMBL959","canonicalSmiles":"CC(N)C12CC3CC(CC(C3)C1)C2","inchiKey":"UBCHPRBFMUDMNC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RIMANTADINE","yearOfFirstApproval":1993,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Rimantadin","Rimantadine"],"crossReferences":{"DailyMed":["rimantadine%20hydrochloride"],"PubChem":["174006857","29215455"],"Wikipedia":["Rimantadine"],"drugbank":["DB00478"]},"childChemblIds":["CHEMBL535396"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1993 and has 3 approved indications."}
